Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer
Dr. Secora is formerly the CFO and Executive Leader of Value Translation at RecursionSAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, a clinical-stage biotechnology...